Articles
The Inhibitory Effects of Curcumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine-Induced Responses in Cardiomyocytes
Citation:
European Cardiology Review 2017;12(2):107.
Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker
Citation:
European Cardiology Review 2017;12(2):96.
Does Angiotensin Receptor Neprilysin Inhibitor (ARNI) Improve Functional Capacity Assessed by 6 Minutes Walking Test?
Citation:
European Cardiology Review 2017;12(2):100.
Cardiac Resynchronization is Associated with Reduction in the Rate of ICD Therapies, While Improves Ventricular Function
Citation:
European Cardiology Review 2017;12(2):93.
A Risk Score to Predict the Absence of Left Ventricular Reverse Remodelling: Implications for the Timing of ICD Implantation in Primary Prevention
Citation:
European Cardiology Review 2017;12(2):99.
Nobiletin a Citrus Flavonoid, Exerts Additional Effects with Angiotensin II Receptor Blocker on Systolic Function in Salt-sensitive Dahl Rats
Citation:
European Cardiology Review 2017;12(2):92.
5-Year Outcomes After Implementation of Optimal Medical Therapy in General Practice Using Liaison Critical Pathway for Secondary Prevention of Coronary Artery Disease: An Observational Study
Citation:
European Cardiology Review 2017;12(2):98.
Cardiovascular Risk Management Targeting Inflammation in Addition to Lipid-lowering Therapy
Citation:
European Cardiology Review 2017;12(2):88
Impact on Patient Care: The 2016 European Heart Failure Guidelines
Citation:
European Cardiology Review 2017;12(2):78–9
